Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents Post author:Sam Post published:November 21, 2017 Post category:BioPharma Genentech is claiming that Pfizer’s proposed biosimilar infringes 40 of its patents. Source: BioSpace You Might Also Like ProMetic Life Sci Reports Its 2016 Fourth Quarter And Year End Highlights And Financial Results March 30, 2017 Bio-Rad Reports Fourth-Quarter And Full-Year 2016 Financial Results February 23, 2017 This Tiny Massachusetts Biotech Could Reap Big Rewards for Investors October 26, 2017
ProMetic Life Sci Reports Its 2016 Fourth Quarter And Year End Highlights And Financial Results March 30, 2017
